CTNM compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

CTNMContineum Therapeutics, Inc.

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

CTNMContineum Therapeutics, Inc.

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CTNM 2

JNJJ&Jcustomer

—WuXi AppTecunlistedsupplier

Shared 0

No shared counterparties.

Only BNTC 2

—Australian governmentunlistedsupplier

—Axovant Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CTNMContineum Therapeutics, Inc.

9.40▲+0.06%· post 9.57

Mkt cap$353.3MRevenue—

BNTCBenitec Biopharma Inc.

8.77▲+0.35%· post 8.38

After hoursNov 2 '26

Mkt cap$304.9MRevenue$7,000Q4 FY23

Compare

After hoursNov 2 '26

CTNMContineum Therapeutics, Inc.

BNTCBenitec Biopharma Inc.

9.40▲+0.06%post 9.57

Price

8.77▲+0.35%post 8.38

$353.3M

Mkt cap

$304.9M

—

Revenue

$7,000Q4 FY23

CTNM9.40▲+0.06%vsBNTC8.77▲+0.35%After hoursNov 2 '26